Co-Diagnostics, Inc.
CODX
$0.344
$0.037412.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 569.40K | 567.60K | 770.00K | 675.90K | 605.50K |
| Total Other Revenue | 434.30K | 2.93M | 3.15M | 6.65M | 8.53M |
| Total Revenue | 1.00M | 3.50M | 3.92M | 7.32M | 9.14M |
| Cost of Revenue | 606.20K | 786.20K | 999.10K | 3.71M | 3.67M |
| Gross Profit | 397.50K | 2.71M | 2.92M | 3.61M | 5.47M |
| SG&A Expenses | 18.62M | 19.59M | 20.64M | 19.92M | 19.63M |
| Depreciation & Amortization | 1.28M | 1.33M | 1.38M | 1.33M | 1.28M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.76M | 41.87M | 44.00M | 47.32M | 47.84M |
| Operating Income | -38.75M | -38.37M | -40.08M | -40.00M | -38.70M |
| Income Before Tax | -35.95M | -35.81M | -37.58M | -37.38M | -35.81M |
| Income Tax Expenses | 38.30K | 46.60K | 57.40K | 3.90M | 1.76M |
| Earnings from Continuing Operations | -35.99 | -35.86 | -37.64 | -41.28 | -37.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.99M | -35.86M | -37.64M | -41.28M | -37.57M |
| EBIT | -38.75M | -38.37M | -40.08M | -40.00M | -38.70M |
| EBITDA | -37.47M | -37.05M | -38.70M | -38.67M | -37.42M |
| EPS Basic | -1.14 | -1.16 | -1.24 | -1.38 | -1.27 |
| Normalized Basic EPS | -0.76 | -0.76 | -0.81 | -0.81 | -0.79 |
| EPS Diluted | -1.15 | -1.17 | -1.24 | -1.38 | -1.27 |
| Normalized Diluted EPS | -0.76 | -0.76 | -0.81 | -0.81 | -0.79 |
| Average Basic Shares Outstanding | 126.53M | 123.54M | 121.34M | 119.93M | 118.80M |
| Average Diluted Shares Outstanding | 126.53M | 123.54M | 121.34M | 119.93M | 118.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |